Oct 17, 2017

China plays all sides of solar fight

China has dominated the solar manufacturing space since at least 2010. Photo: Ng Han Guan / AP

Chinese interests are coming up all over a fight playing out within America's solar industry about how the Trump administration should address a flood of cheap solar imports, coming mostly from China or Chinese-owned companies.

Why it matters: The dynamic reveals how widespread Chinese interests are in clean energy, and in particular solar manufacturing, a space it has dominated since at least 2010. President Trump has said he wants to reverse decades of open-trade policies to help protect American jobs and manufacturing. It would take huge policy changes and a lot of time to reduce China's dominance.

Driving the news: The International Trade Commission is considering what type of trade remedy to recommend President Trump employ to address the cheap solar imports. The independent federal agency unanimously voted in September that those imports have economically injured two U.S.-based but foreign-owned solar manufacturers. Trump will ultimately decide whether to impose tariffs or another kind of remedy, and most expect he will given his protectionist bent.

China on one side: One of the companies asking for trade protections, Suniva, is Georgia-based but is majority owned by a Chinese company. The company was trying to manufacture in the United States and recoup costs after filing for bankruptcy earlier this year. That's what fueled its decision to join the trade case brought by German-owned but Oregon-based SolarWorld Americas.

To make the situation even more complicated, the majority Chinese owner of the company, Shunfeng International Clean Energy Ltd., told the ITC it doesn't want the remedies, but the company itself is pushing hard for them.

China on the other side: A Chinese trade group, the China Chamber of Commerce for Import and Export of Machinery and Electronic Products, has issued briefs backing arguments against the trade remedies by the Solar Energy Industries Association, a U.S. trade group. SEIA opposes the two companies' push because the cheap imports have fueled a boom in most parts of the industry other than manufacturing, including engineering and installation jobs.

"Chinese solar panels are absolutely critical to the U.S. market and the overall U.S. solar industry," said Spencer Griffith, a lawyer at Akin Gump who represents the Chinese group in the case. "U.S. producers of cells and modules cannot come close to satisfying U.S. demand, and the draconian remedies the petitioners propose would cripple the U.S. market and U.S. demand."

Hypocrisy on both sides:

  • Mutual support between the U.S. and Chinese trade groups as well as advertising campaigns pushed by U.S. groups led a top executive at Suniva to publicly allege last week that SEIA was doing the bidding of China.
  • A SEIA spokesman said SEIA has close to a 1,000 member companies and only a dozen or so are China-based companies. "We proudly represent America's solar industry," said spokesman Dan Whitten. "The notion that we advocate primarily for Chinese interests is laughable and a stunning allegation from a company that itself is majority-owned by a Chinese company."

China on yet another side: The Justice Department in 2014 indicted Chinese military hackers for what DOJ said at the time was cyber espionage against U.S. corporations, including SolarWorld, for commercial advantage. A top SolarWorld Americas executive testified about that case earlier this month to the United States Trade Representative. That hearing was part of the Trump administration's investigation into alleged Chinese violations of intellectual property, so expect this issue to resurface.

Go deeper: Check out Amy's latest Harder Line column on this topic, and this E&E story for a deep dive into Suniva's ownership.

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 665,164 — Total deaths: 30,852 — Total recoveries: 140,225.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 3 a.m. ET: 124,665 — Total deaths: 2,191 — Total recoveries: 1,095.
  3. Federal government latest: President Trump announces new travel advisories for New York, New Jersey and Connecticut, but rules out quarantine enforcement. Per the CDC, residents of those states must now "refrain from non-essential domestic travel for 14 days," with the exception of critical infrastructure industry workers.
  4. State updates: Alaska is latest state to issue a stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month and has moved its presidential primary to June 23. Some Midwestern swing voters who backed Trump's handling of the virus less than two weeks ago are balking at his call for the U.S. to be "opened up" by Easter.
  5. World updates: In Spain, over 1,400 people were confirmed dead between Thursday to Saturday.
  6. 🚀 Space updates: OneWeb filed for bankruptcy amid the novel coronavirus pandemic.
  7. Hollywood: Tom Hanks and Rita Wilson have returned to U.S. after being treated for coronavirus.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Coronavirus updates: Global death toll tops 30,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.

The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by early Sunday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.

Go deeperArrowUpdated 3 hours ago - Health

Gilead expands access to experimental coronavirus drug in emergency cases

Photo: Olivier Douliery/AFP via Getty Images

Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.

The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness the treatment of the novel coronavirus has yet to be proved. The World Health Organization is involved in the tests.

Go deeperArrow3 hours ago - Health